Cholesterol appears to promote tamoxifen resistance in some breast cancer cells

Breast cancer cells in the laboratory that don't respond to tamoxifen may be producing high amounts of cholesterol in order to provide a kind of shield against the drug, say researchers at Georgetown University Medical Center (GUMC).

If you want to include this story in your blog, copy and paste this formatted text: